Acne: trifarotene nets FDA approval

  • Galderma.com

  • Brian Richardson, PhD
  • Clinical Essentials
L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano

Takeaway

  • Trifarotene (Aklief) cream 0.005% has been approved by the FDA for topical treatment of acne.

Why this matters

  • Retinoid molecule has shown efficacy for face and trunk acne.

Key results

  • In phase 3 trials, trifarotene was associated with reduced inflammatory lesions on the face, back, shoulders, and chest compared with vehicle (P<.05>
  • The most common adverse reactions were application site irritation, application site pruritus, and sunburn.

Study design